
zzso of plasma protein binding will provide zzso insights into drug interactions or unusual zzso zzso This study investigated zzso binding in plasma and its implications for the zzso and zzso of this zzso 

zzso binding to plasma proteins was determined using a validated equilibrium dialysis zzso zzso of total and zzso zzso was evaluated in eight patients with breast cancer receiving zzso alone and in combination with the zzso inhibitor zzso The impact of protein binding on zzso zzso was assessed using an in zzso zzso cellular zzso 

zzso was extensively bound in human zzso with the total binding constant of zzso zzso zzso and zzso zzso zzso zzso for zzso zzso zzso and zzso zzso zzso competitively inhibited zzso binding to zzso In patients, zzso fraction zzso zzso exhibited large zzso and zzso zzso zzso increased zzso zzso by an average of zzso zzso zzso significantly decreased total (but not zzso zzso zzso zzso zzso was strongly correlated with the total drug zzso zzso to zzso zzso zzso in zzso zzso zzso 

zzso is highly bound in human plasma with high affinity to zzso Changes in plasma protein binding caused by zzso drug zzso zzso or disease states zzso zzso level in zzso can alter total (but not zzso zzso zzso zzso zzso is zzso zzso Monitoring of zzso zzso plasma concentration is recommended to avoid misleading conclusions on the basis of the total drug zzso 

